Author Question: The nurse provides education to the patient and family about fluorouracil (Adrucil). What statement ... (Read 36 times)

mwit1967

  • Hero Member
  • *****
  • Posts: 501
The nurse provides education to the patient and family about fluorouracil (Adrucil). What statement by the patient most demonstrates the need for further teaching?
 
  a. I may experience darkening skin in some areas of my body.
  b. I should report diarrhea.
  c. I shouldn't anticipate blistering on my palms and soles.
  d. I probably will lose my hair.

Question 2

A patient on an oncology unit has been receiving ifosfamide (Ifex) for a few days. Prior to administration of the next dose, the nurse reviews the patient's laboratory test results. Which finding would cause the nurse to hold the dose?
 
  a. Low levels of ketones in the urine
  b. Hematuria
  c. Blurred vision
  d. Low Hct and Hb



Dominic

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

ANS: C
The patient may experience blistering on the palms and soles; this statement indicates that further teaching is required.
The patient may experience darkening of the skin in some areas; no further teaching is required.
The medication should be discontinued as soon as mild reactions like stomatitis and diarrhea occur.
The patient likely will lose his hair; no further teaching is required.

Answer to Question 2

ANS: B
The nurse should hold the dose for hematuria, because this may indicate hemorrhagic cystitis.
Ketones may reveal some other problem, but they are not associated with ifosfamide.
Blurred vision is a symptom of toxicity; however, the question specifically asks about a laboratory result.
Low Hct and Hb are expected for a patient undergoing chemotherapy.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library